An indication for a pacemaker or implantable cardioverter-defibrillator (ICD) in a patient with an intracardiac shunt requires a balancing of the risks and benefits associated with a transvenous ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Complications related to transvenous pacemakers have ...

Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...

Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...

THROMBOEMBOLISM has not been a clinical problem after insertion of transvenous pacemaker electrodes despite the presence of an intracardiac foreign body. This report documents the presence of a large ...

Medtronic (NYSE:MDT) today announced CE mark approval and the first commercial European implants for its OmniaSecure system.

There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

Despite being at higher risk of complications overall, Medicare beneficiaries who receive a Micra leadless pacemaker (Medtronic) fare better than those implanted with traditional transvenous systems, ...

Good news for heart patients. If you want to keep your heart healthy, you should opt for leadless pacemakers over the conventional transvenous variants. While you can you avoid heart attack and stroke ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...